ARMENI, Patrizio

ARMENI, Patrizio  

Mostra records
Risultati 1 - 11 di 11 (tempo di esecuzione: 0.016 secondi).
Titolo Data di pubblicazione Autore(i) File
Accounting and funding of pharmaceuticals. Purpose, structure and management of the File F in nine Italian regions 1-gen-2016 Costa, F.; Armeni, P.; Otto, M. H.; Amoroso, N.; Jommi, C.
Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non–small Cell Lung Cancer in the Italian National Health Service 1-gen-2020 Armeni, P.; Borsoi, L.; Fornaro, G.; Jommi, C.; Grossi, F.; Costa, F.
Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service 1-gen-2020 Armeni, P.; Borsoi, L.; Fornaro, G.; Jommi, C.; Colombo, N.; Costa, F.
De innovatione: The concept of innovation for medical technologies and its implications for healthcare policy-making 1-gen-2016 Ciani, O.; Armeni, P.; Boscolo, P. R.; Cavazza, M.; Jommi, C.; Tarricone, R.
Early access programs and managed entry agreements for medicines in Italy: Results of a Focus Group (Early Access Programs and Managed Entry Agreement) 1-gen-2021 Jommi, C.; Armeni, P.; Costa, F.; Alberti, C.; Bandello, F.; Bordonaro, R.; Caprodossi, A.; Di Maio, M.; Gaudioso, A.; Giuliani, G.; Langella, R.; Marata, A. M.; Patarnello, F.; Pinto, C.; Rasi, G.; Villa, F.
Implementation of Value-based Pricing for Medicines 1-gen-2020 Jommi, C.; Armeni, P.; Costa, F.; Bertolani, A.; Otto, M.
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study 1-gen-2018 Jommi, C.; Armeni, P.; Battista, M.; di Procolo, P.; Conte, G.; Ronco, C.; Cozzolino, M.; Costanzo, A. M.; di Luzio Paparatti, U.; Concas, G.; Remuzzi, G.
The future of Funds for Innovative Medicines: results from a Delphi Study 1-gen-2021 Jommi, Claudio; Armeni, Patrizio; Bertolani, Arianna; Costa, Francesco; Otto, Monica
The impact of HTA and procurement practices on the selection and prices of medical devices 1-gen-2017 Callea, G.; Armeni, P.; Marsilio, M.; Jommi, C.; Tarricone, R.
The simultaneous effects of pharmaceutical policies from payers’ and patients’ perspectives: Italy as a case study 1-gen-2016 Armeni, P.; Jommi, C.; Otto, M.
Variations in non-prescription drug consumption and expenditure: Determinants and policy implications 1-gen-2018 Otto, M.; Armeni, P.; Jommi, C.